By Sydney Halleman
Published July 22, 2026
In a move that signals a deepening commitment to the "hospital-at-home" paradigm, healthcare giant Cardinal Health announced on Monday that it has entered into definitive agreements to acquire a specialized diabetes health business from AdaptHealth, alongside the medical supplier Strive Medical. The dual acquisition, valued at $235 million, represents a calculated step to bolster Cardinal’s rapidly expanding in-home solutions unit—a segment that has become a cornerstone of the company’s recent financial success.
While the total consideration for the two transactions is $235 million, industry analysts estimate that the Strive Medical portion of the deal accounts for approximately $125 million, with the remaining $110 million allocated to the AdaptHealth diabetes assets. As the healthcare industry continues its post-pandemic pivot toward decentralized care models, these acquisitions position Cardinal Health to capture a larger share of the lucrative direct-to-patient supply market.
The Strategic Rationale: Moving Care to the Patient
The healthcare sector is undergoing a profound structural shift. With payers and providers increasingly incentivized to reduce hospital readmissions and lower the cost of chronic disease management, the "at-home" setting has transitioned from a niche service to a standard of care.
Cardinal Health has been at the forefront of this transition. By delivering essential medical supplies—ranging from continuous glucose monitors (CGMs) to advanced wound care kits—directly to a patient’s doorstep, the company minimizes the friction associated with chronic condition management. This model not only improves patient adherence to treatment plans but also offers a scalable, high-margin revenue stream for the distributor.
Executives at Cardinal emphasized that these acquisitions are not merely defensive plays but are essential components of a broader strategy to become the primary partner for patients navigating chronic illness outside of clinical settings.
Chronology of Expansion: Building a Direct-to-Patient Empire
To understand the significance of this week’s announcement, one must look at the aggressive M&A trajectory Cardinal Health has pursued over the last 24 months.
- April 2025: Cardinal Health closes the $1.1 billion acquisition of Advanced Diabetes Supply (ADS). This deal was a watershed moment, immediately onboarding nearly 500,000 new customers and establishing a formidable footprint in the diabetes management space.
- August 2025: Seeking to diversify its specialty offerings, Cardinal acquires Solaris Health, a leading urology multi-specialty organization. This move underscored the company’s intent to move beyond general supplies and into specialized care verticals.
- July 22, 2026: Cardinal announces the simultaneous acquisition of AdaptHealth’s diabetes business and Strive Medical. This expansion deepens the company’s expertise in both diabetes and the broader categories of urology, ostomy, and incontinence care.
The rapid integration of these businesses has been a point of pride for Cardinal’s leadership. The company noted that the ADS acquisition, which took place just over a year ago, has been integrated into the corporate ecosystem faster than initial projections, proving the company’s capability to absorb and scale high-growth assets.
Supporting Data: The Financial Boon of Home Care
The financial performance of Cardinal’s "Other" business segment—which houses the at-home solutions unit—justifies the aggressive capital allocation. In the third quarter of 2026, this unit contributed a staggering $1.7 billion in revenue.
More impressively, the segment saw a 34% year-over-year growth in profit. This surge in profitability was significant enough to prompt management to upwardly revise their profit guidance for the entire fiscal year ending June 30.
Key Performance Indicators:
- AdaptHealth Diabetes Unit: Serves over 225,000 patients annually. Its primary product focus is the direct-to-patient delivery of CGMs and related testing supplies.
- Strive Medical: Adds a new layer of clinical depth, serving over 20,000 customers per year with a focus on urology, wound care, and ostomy supplies.
- Segment Profitability: The 34% YoY profit increase in the "Other" segment highlights the operational efficiency Cardinal gains by layering new customer bases onto its existing, sophisticated logistics and freight infrastructure.
Official Responses and Corporate Strategy
In an official statement regarding the divestiture, AdaptHealth framed the sale as a strategic alignment of its own portfolio. By shedding the diabetes health business, AdaptHealth is effectively streamlining its operations, while Cardinal Health gains a ready-made, high-volume patient base.
Cardinal Health executives highlighted that the acquisitions are highly complementary. By combining the scale of their existing diabetes supply chain with the specialized clinical expertise found in Strive Medical’s urology and wound care portfolios, Cardinal is creating a "one-stop shop" for patients with complex, long-term medical needs.
"We are building a robust ecosystem that meets the patient where they live," a company representative noted. "The speed at which we onboarded the ADS customers proves that our logistical infrastructure is capable of handling rapid scaling without compromising the quality of care."
Implications for the Healthcare Landscape
The ripple effects of this deal extend beyond the balance sheets of Cardinal and AdaptHealth. Several key implications emerge for the broader medical supply industry:
1. Consolidation of the "Home-Care" Middlemen
As large distributors like Cardinal acquire specialized suppliers, the market for home medical supplies is becoming increasingly consolidated. This creates barriers to entry for smaller players but offers significant benefits to patients, who gain access to integrated platforms that handle everything from insurance verification to automated reordering.
2. The Rise of the Specialty Supplier
The acquisition of Strive Medical signals that Cardinal is interested in more than just "commodity" supplies. By moving into ostomy and urology, they are entering markets that require higher levels of patient education and clinical support. This represents a pivot from simple product distribution to a more integrated, service-oriented care model.
3. Pressure on Traditional Pharmacy Chains
As companies like Cardinal Health continue to expand their direct-to-patient delivery models, traditional pharmacy and retail health chains face increased pressure. If a patient can receive high-end diabetic and wound care supplies directly from a dedicated, specialized supplier, the value proposition of visiting a brick-and-mortar pharmacy for these items diminishes.
Conclusion: Looking Ahead
While Cardinal did not disclose a projected closing date for the latest deals, the regulatory path is expected to be straightforward given the nature of the assets.
Moving forward, the primary challenge for Cardinal Health will be maintaining its high standard of customer service as it scales. With hundreds of thousands of new patients added to their rolls over the past 18 months, the company’s ability to manage logistics, inventory, and, most importantly, patient satisfaction will be the ultimate test of their home-care strategy.
For now, the markets appear to support the move. By betting on the permanency of the home-care trend, Cardinal Health is not just reacting to the market—it is helping to define it. As the population ages and the prevalence of chronic conditions continues to rise, the infrastructure built by Cardinal today will likely serve as the backbone for the patient care of tomorrow.
